Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrin Reetz

Showing results (151-160 of 196) with videos related to

Pageof 20
Sort By:
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Fortschritte Der Neurologie-Psychiatrie|July 20, 2022
[The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]Oezguer A Onur, Claus Wolff-Menzler, Christine A F von Arnim, et al.
The Lancet. Neurology|January 9, 2015
Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline dataKathrin Reetz, Imis Dogan, Ana S Costa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease SeverityHolger Hengel, Peter Martus, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 9, 2022
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3Roderick P P W M Maas, Steven Teerenstra, Manuela Lima, et al.
CNS Drugs|October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI CohortPatrick Silva, Marina A Costa, Laetitia Gaspar, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2024
The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping ReviewLuigi Lavorgna, Elisabetta Maida, Carola Reinhard, et al.
Journal of Neurology|December 21, 2024
Subtypes of cognitive impairment in cerebellar disease identified by cross-diagnostic cluster-analysis: results from a German multicenter studyQi Liu, Kerstin Rubarth, Jennifer Faber, et al.
European Journal of Neurology|January 11, 2025
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history studyStella Andrea Lischewski, Kerstin Konrad, Imis Dogan, et al.
Cerebellum (London, England)|June 23, 2026
Transitional Life Events in Friedreich Ataxia: Differential Age at Onset PerspectivesAudrey Iskandar, Maresa Buchholz, Dorota Sarwinska, et al.
Pageof 20

Showing results (151-160 of 196) with videos related to

Sort By:
Pageof 20
Movement Disorders : Official Journal of the Movement Disorder Society|August 16, 2021
Polyglutamine-Expanded Ataxin-3: A Target Engagement Marker for Spinocerebellar Ataxia Type 3 in Peripheral BloodJeannette Hübener-Schmid, Kirsten Kuhlbrodt, Julien Peladan, et al.
Fortschritte Der Neurologie-Psychiatrie|July 20, 2022
[The Cost of Early Diagnosis of Cognitive Decline in German Memory Clinics]Oezguer A Onur, Claus Wolff-Menzler, Christine A F von Arnim, et al.
The Lancet. Neurology|January 9, 2015
Biological and clinical characteristics of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS) cohort: a cross-sectional analysis of baseline dataKathrin Reetz, Imis Dogan, Ana S Costa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|October 29, 2021
Characterization of Lifestyle in Spinocerebellar Ataxia Type 3 and Association with Disease SeverityHolger Hengel, Peter Martus, Jennifer Faber, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 9, 2022
Differential Temporal Dynamics of Axial and Appendicular Ataxia in SCA3Roderick P P W M Maas, Steven Teerenstra, Manuela Lima, et al.
CNS Drugs|October 17, 2025
The Medication Patterns of Spinocerebellar Ataxia Type 3 Mutation Carriers Enrolled in the ESMI CohortPatrick Silva, Marina A Costa, Laetitia Gaspar, et al.
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|July 1, 2024
The Growing Role of Telerehabilitation and Teleassessment in the Management of Movement Disorders in Rare Neurological Diseases: A Scoping ReviewLuigi Lavorgna, Elisabetta Maida, Carola Reinhard, et al.
Journal of Neurology|December 21, 2024
Subtypes of cognitive impairment in cerebellar disease identified by cross-diagnostic cluster-analysis: results from a German multicenter studyQi Liu, Kerstin Rubarth, Jennifer Faber, et al.
European Journal of Neurology|January 11, 2025
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history studyStella Andrea Lischewski, Kerstin Konrad, Imis Dogan, et al.
Cerebellum (London, England)|June 23, 2026
Transitional Life Events in Friedreich Ataxia: Differential Age at Onset PerspectivesAudrey Iskandar, Maresa Buchholz, Dorota Sarwinska, et al.
Pageof 20